CURCIO, ANNALISA
 Distribuzione geografica
Continente #
EU - Europa 602
NA - Nord America 496
AS - Asia 148
AF - Africa 20
OC - Oceania 1
Totale 1.267
Nazione #
US - Stati Uniti d'America 483
DE - Germania 248
IT - Italia 154
SG - Singapore 102
UA - Ucraina 102
NL - Olanda 43
CN - Cina 38
CI - Costa d'Avorio 20
FI - Finlandia 15
SE - Svezia 13
CA - Canada 12
FR - Francia 10
IE - Irlanda 4
RU - Federazione Russa 4
TR - Turchia 4
CZ - Repubblica Ceca 3
IN - India 3
GB - Regno Unito 2
HU - Ungheria 2
AU - Australia 1
GR - Grecia 1
LT - Lituania 1
MX - Messico 1
TW - Taiwan 1
Totale 1.267
Città #
Chandler 127
Singapore 93
Santa Clara 49
Jacksonville 40
Amsterdam 38
Krefeld 24
Millbury 20
Naples 18
Beijing 15
Princeton 15
Boston 12
Bad Durrheim 11
Ashburn 9
Napoli 9
Ottawa 9
Wilmington 7
Houston 5
Montescaglioso 5
Nanchang 5
Nanjing 5
Norwalk 5
Hebei 4
Kronberg 4
Lawrence 4
Paris 4
Siena 4
Siracusa 4
Abidjan 3
Brno 3
Castellammare Di Stabia 3
Pomigliano D'arco 3
Potenza 3
Andover 2
Budapest 2
Calgary 2
Caserta 2
Dallas 2
Dublin 2
Falls Church 2
Frankfurt am Main 2
Kunming 2
Moscow 2
Pune 2
Redwood City 2
Rende 2
Salò 2
Shenyang 2
Varedo 2
Woodbridge 2
Altavilla Silentina 1
Boardman 1
Brisbane 1
Castelpagano 1
Changchun 1
Dearborn 1
Eindhoven 1
Fairfield 1
Fisciano 1
Fort Worth 1
Giugliano In Campania 1
Hanover 1
Melito di Napoli 1
Milan 1
Monza 1
New York 1
Nocera Superiore 1
Orange 1
Orta di Atella 1
Padova 1
Piraeus 1
Pozzuoli 1
Reggio Calabria 1
Rimini 1
San Mateo 1
Seattle 1
Shanghai 1
Shenzhen 1
Solofra 1
Stella Cilento 1
Stockholm 1
Toronto 1
Turin 1
Totale 627
Nome #
2-fenil-imidazo[1,2-B]piridazine ad attività analgesica ed antiepilettica 137
Derivati glicosilati della Nω-Nitro-L-Arginina come agenti antitumorali 107
Italian Society of Cardiology (SIC) Expert consensus document: Post-acute cardiovascular sequelae of SARS-CoV-2 infection 107
Profarmaco galattosilato del ketorolac ad uso analgesico e antinfiammatorio con migliori caratteristiche farmacocinetiche e profilo tossicologico del farmaco di partenza 101
Composizioni farmaceutiche a base di zeoliti porose quali mezzi di rilascio di molecole farmacologicamente attive e relativo uso 71
D-Galactose as a Vector for Prodrug Design. 59
Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice 58
Galactosylated dopamine enters into the brain, blocks mesocorticolimbic system and modulates activity and scanning time in naples high excitability rats 56
L’esercizio fisico riduce l’iperplasia neointimale dopo angioplastica o stenting. 56
Galactosyl Derivative of N(omega)-Nitro-L-Arginine: Study of Antiproliferative Activity on Human Thyroid Follicular Carcinoma Cells 56
Synthetic Zeolites as a New Tool for Drug Delivery 54
Pharmaceutical compositions based on porous zeolites as release means of pharmacologically active molecules and relative use 50
Profarmaco galattosilato della N-omega-nitro-L-arginina (nagal) ad uso analgesico ed antinfiammatorio con migliore caratteristiche farmacocinetiche e di tollerabilità del farmaco di partenza 50
Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect 50
Sol-gel processing of anti-inflammatory entrapment in Silica, release kinetics and bioactivity 45
Excitatory amino acids in the forebrain of the Naples high-excitability rats: Neurochemical and behavioural effects of subchronic d-aspartate and its diethyl ester prodrug 36
Position paper of the Italian Society of Cardiology (SIC) on COVID-19 vaccine priority in patients with cardiovascular diseases 26
The instantaneous wave-free ratio (iFR) for evaluation of non-culprit lesions in patients with acute coronary syndrome and multivessel disease 24
Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case-control study 22
Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice 20
Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials 20
Italian Society of Cardiology-Italian Society of Nephrology Consensus Document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage 17
A New Human-Derived Acellular Dermal Matrix for Breast Reconstruction Available for the European Market: Preliminary Results 15
Modern subcutaneous implantable defibrillator therapy in patients with cardiomyopathies and channelopathies: Data from a large multicentre registry 11
Molecular therapeutic strategies in cardiology 11
Italian Society of Cardiology-Italian Society of Nephrology Consensus Document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal damage 10
The gray areas of oral anticoagulation for prevention of thromboembolic events in atrial fibrillation patients 8
Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing 6
Cardiovascular Prognosis in Patients with Peripheral Artery Disease and Approach to Therapy 6
Is routine axillary lymph node dissection needed to tailor systemic treatments for breast cancer patients in the era of molecular oncology? A position paper of the Italian National Association of Breast Surgeons (ANISC) 1
Totale 1.290
Categoria #
all - tutte 5.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.109


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 0 0 0 0 0 2 0 4 6 11 19
2020/2021191 9 15 24 19 25 22 23 8 11 3 28 4
2021/2022119 6 3 4 4 3 2 2 2 4 0 47 42
2022/2023370 22 28 12 26 31 31 8 19 40 42 111 0
2023/2024114 4 16 11 2 4 19 4 22 4 0 21 7
2024/2025184 52 58 2 3 29 40 0 0 0 0 0 0
Totale 1.290